ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2022

Study on the potential of Sanghuangporus sanghuang and its components as COVID-19 spike protein receptor binding domain inhibitors.

Liang-Hsuan Chien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.